2415 — MedSci Healthcare Holdings Cashflow Statement
0.000.00%
- HK$689.87m
- -HK$664.52m
- CNY270.37m
Annual cashflow statement for MedSci Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -147 | -96.3 | 60.5 | 25.5 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 200 | 108 | -15.9 | -6.21 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -23.9 | -34.3 | -14.9 | 28.3 | — |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 37.4 | -14 | 38 | 54.8 | — |
| Capital Expenditures | -0.889 | -2.16 | -1.95 | -0.346 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.15 | 0.031 | -493 | -316 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.03 | -2.13 | -495 | -317 | — |
| Financing Cash Flow Items | -3.88 | 0 | 520 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 286 | -7.52 | 471 | -4.42 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 319 | 3.26 | 29.3 | -262 | — |